Sales decline 19.32% to Rs 121.63 crore
Net Loss of Sterling Biotech reported to Rs 127.38 crore in the quarter ended December 2014 as against net loss of Rs 105.99 crore during the previous quarter ended December 2013. Sales declined 19.32% to Rs 121.63 crore in the quarter ended December 2014 as against Rs 150.75 crore during the previous quarter ended December 2013.For the full year,net loss reported to Rs 457.71 crore in the year ended December 2014 as against net loss of Rs 400.65 crore during the previous year ended December 2013. Sales declined 7.12% to Rs 666.95 crore in the year ended December 2014 as against Rs 718.07 crore during the previous year ended December 2013.
ParticularsQuarter EndedYear EndedDec. 2014Dec. 2013% Var.Dec. 2014Dec. 2013% Var.Sales121.63150.75 -19 666.95718.07 -7 OPM %-5.6515.18 -12.5313.78 - PBDT-94.47-92.45 -2 -385.92-338.76 -14 PBT-179.27-156.89 -14 -662.49-593.08 -12 NP-127.38-105.99 -20 -457.71-400.65 -14
Powered by Capital Market - Live News
